Abstract 17706: Outcomes of P2Y12 Inhibitor Monotherapy versus Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Complex Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis
Background: Optimizing antithrombotic therapy after complex percutaneous coronary intervention (PCI) in patients at high bleeding risk (HBR) remains a critical clinical challenge. While dual antiplatelet therapy (DAPT) reduces ischemic events, it carries higher bleeding burden in this population. P2Y12 inhibitor mon...